Endovascular management for significant iatrogenic portal vein bleeding
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jong Woo | - |
dc.contributor.author | Shin, Ji Hoon | - |
dc.contributor.author | Park, Jonathan K. | - |
dc.contributor.author | Yoon, Hyun-Ki | - |
dc.contributor.author | Ko, Gi-Young | - |
dc.contributor.author | Gwon, Dong Il | - |
dc.contributor.author | Kim, Jin Hyoung | - |
dc.contributor.author | Sung, Kyu-Bo | - |
dc.date.available | 2020-02-27T16:42:53Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-11 | - |
dc.identifier.issn | 0284-1851 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5490 | - |
dc.description.abstract | Background: Despite conservative treatment, hemorrhage from an intrahepatic branch of the portal vein can cause hemodynamic instability requiring urgent intervention. Purpose: To retrospectively report the outcomes of hemodynamically significant portal vein bleeding after endovascular management. Material and Methods: During a period of 15 years, four patients (2 men, 2 women; median age, 70.5 years) underwent angiography and embolization for iatrogenic portal vein bleeding. Causes of hemorrhage, angiographic findings, endovascular treatment, and complications were reported. Results: Portal vein bleeding occurred after percutaneous liver biopsy (n = 2), percutaneous radiofrequency ablation (n = 1), and percutaneous cholecystostomy (n = 1). The median time interval between angiography and percutaneous procedure was 5 h (range, 4-240 h). Common hepatic angiograms including indirect mesenteric portograms showed active portal vein bleeding into the peritoneal cavity with (n = 1) or without (n = 2) an arterioportal (AP) fistula, and portal vein pseudoaneurysm alone with an AP fistula (n = 1). Successful transcatheter arterial embolization (n = 2) or percutaneous transhepatic portal vein embolization (n = 2) was performed. Embolic materials were n-butyl cyanoacrylate alone (n = 2) or in combination with gelatin sponge particles and coils (n = 2). There were no major treatmentrelated complications or patient mortality within 30 days. Conclusion: Patients with symptomatic or life-threatening portal vein bleeding following liver-penetrating procedures can successfully be managed with embolization. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.relation.isPartOf | ACTA RADIOLOGICA | - |
dc.title | Endovascular management for significant iatrogenic portal vein bleeding | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000410933900006 | - |
dc.identifier.doi | 10.1177/0284185117693458 | - |
dc.identifier.bibliographicCitation | ACTA RADIOLOGICA, v.58, no.11, pp.1320 - 1325 | - |
dc.identifier.scopusid | 2-s2.0-85029699144 | - |
dc.citation.endPage | 1325 | - |
dc.citation.startPage | 1320 | - |
dc.citation.title | ACTA RADIOLOGICA | - |
dc.citation.volume | 58 | - |
dc.citation.number | 11 | - |
dc.contributor.affiliatedAuthor | Kim, Jong Woo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Portal vein bleeding | - |
dc.subject.keywordAuthor | endovascular management | - |
dc.subject.keywordAuthor | iatrogenic | - |
dc.subject.keywordAuthor | liver-penetrating procedure | - |
dc.subject.keywordAuthor | embolization | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.